Answer
Known, previous or suspected breast cancer is a contraindication. Combined systemic HRT is associated with an increased breast-cancer risk that rises with longer use.
Sources for this answer
- Indivina 1 mg/5 mg tablets — Current selected SmPCemc · Summary of Product Characteristics
- UK Government